| Business Summary | | Medstone
International
Inc.
manufactures,
markets
and
maintains
lithotripters,
and
continues
to
expand
its
Fee-for-Service
Program
to
supply
lithotripsy
equipment
to
providers
on
a
per
procedure
basis.
The
lithotripters
manufactured
by
Medstone
are
approved
to
treat
both
kidney
stones
and
gallstones.
The
Company
is
also
marketing
a
urology
imaging
and
treatment
table,
used
for
various
urological
functions,
mobile
urology
and
pain
management
table
to
serve
the
mobile
treatment
market
and
various
radiology
room
equipment. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | MEDS
designs,
manufactures,
markets
and
services
the
Medstone
STSTM
Shockwave
Therapy
System
for
the
noninvasive
disintegration
of
kidney
stones.
For
the
three
months
ended
3/31/01,
revenues
fell
18%
to
$5
million.
Net
income
fell
62%
to
$351
thousand.
Revenues
reflect
lower
average
per
patient
reimbursement.
Net
income
also
reflects
increased
cost
of
sales
as
a
percentage
of
revenues
due
to
an
increase
in
manufacturing
overhead
expenses. Recent Earnings Announcement For
the
3
months
ended
06/30/2001,
revenues
were
5,580;
after
tax
earnings
were
230. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| David Radlinski, 56 CEO,
Chairman | $252K | Mark Selawski, 45 CFO,
VP-Fin., Sec. | 107K | Eva Novotny, 43 Exec.
VP of Sales and Marketing | 126K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|